enVVeno Medical Corporation

NVNO | NASDAQ

Price Alert Chart Builder DCF Calculator

$9.05

+$0.08 (+0.84%)

At close: Sep 21, 2026, 4:00 PM ET

$9.05

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.84%

(1D)

Rating

Updated: Aug 10, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $149.35K

1D Range

8.59 9.16

52W Range

7.01 35.70

Valuation (TTM)

PE -0.02

PB 0.01

EV/EBITDA 1.34

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target N/A

Cash Flow

FCF Yield -9790.3%

SBC Adj. FCF Yield -11256.0%

SBC Impact -15.0%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 51.1% | 30.2%

FCF 3Y | 5Y 6.3% | -1.6%

Returns

ROA -69.4%

ROE -62.3%

ROIC -79.1%

Financial Health

Net Cash

$21.49M

Current Ratio 11.70

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer ad...

Sector Healthcare

Industry Medical - Devices

Employees 33

IPO Date May 30, 2018

Website www.envveno.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Oct 30, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞